Baltic – Chronic Kidney Disease+Hypertension

  • Study Sponsor and Protocol Number: 
    AstraZeneca / D6972C00006
  • Specialty:
    Nephrology
  • Type:
    Investigational Drug in combination with a known medication (Dapagliflozin)
  • Inclusion:
    Hypertension
    eGFR between 30-90
    Urine albumin creatinine ratio between 200-5000
  • Exclusion:
    Type 1 diabetes
    Class 4 heart failure
    Hyperkalaemia